News

Events
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative Medicine
11 years ago Feb 26, 2014
VANCOUVER, BC – February 27, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...
As Seen In
RepliCel Life Sciences Inc. (TSXV: RP) Seeks to Heal with Patients Own Cells
11 years ago Feb 25, 2014
 FINANCIAL POST ARTICLE PUBLISHED ON FEBRUARY 25, 2014Imagine using healthy cells from your body to...
Press Release
RepliCel Retains Ubika Communication for Online Capital Market Exposure
11 years ago Feb 25, 2014
VANCOUVER, BC – February 26, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF),...
Press Release
RepliCel Receives Japanese Patent Covering its Hair Regeneration Technology
11 years ago Jan 12, 2014
VANCOUVER, BC – January 13, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)...
As Seen In
Vancouver hair-loss biotech wins Japanese patent
11 years ago Jan 12, 2014
BUSINESS IN VANCOUVER ARTICLE PUBLISHED ON JANUARY 13, 2014 Vancouver-based RepliCel Life Sciences Inc., a...
Events
RepliCel Life Sciences to Present at Biotech Showcase™ 2014
11 years ago Jan 08, 2014
Vancouver, Canada – January 9, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CSE: RP),...
Press Release
RepliCel to Commence Trading on the TSX Venture Exchange
11 years ago Jan 08, 2014
VANCOUVER, BC – January 9, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CSE: RP)...
Press Release
RepliCel Announces Conditional Approval from TSX Venture Exchange
11 years ago Jan 01, 2014
VANCOUVER, BC – January 2, 2014 –RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCQB:...
Press Release
RepliCel Reports Progress on Shiseido Technology Transfer for RCH-01 Treatment for Pattern Baldness
11 years ago Dec 18, 2013
VANCOUVER, BC – December 19, 2013 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CNSX: RP)...
Press Release
RepliCel Reports Third Quarter 2013 Financial Results and Provides Corporate Update
11 years ago Nov 19, 2013
VANCOUVER, BC – November 20, 2013 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CNSX: RP),...
As Seen In
A cure for baldness? Stem cell researchers race to regenerate follicles from hair resistant to loss
11 years ago Oct 30, 2013
The cure for baldness? It could be closer than you think — i.e. among the...
Press Release
RepliCel Forms Clinical Advisory Board to Support the Development of RCT-01 for the Treatment of Chronic Tendinosis
11 years ago Oct 29, 2013
VANCOUVER, BC – October 30, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...
As Seen In
Stem Cell Technology Used in Search for the Holy Grail of Hair Treatments: a Cure for Baldness
11 years ago Oct 27, 2013
Hisae Nakamura, director of research and development for RepliCel, with a device used to inject...
Press Release
RepliCel Announces Stock Option Grant
12 years ago Sep 05, 2013
VANCOUVER, BC – September 6, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...
Press Release
RepliCel Retains Westwicke Partners as Investor Relations Counsel
12 years ago Sep 03, 2013
VANCOUVER, BC – September 4, 2013 – RepliCel Life Sciences Inc. (OTCBB: REPCF) (CNSX: RP),...
Press Release
RepliCel Announces Closing of Private Placement
12 years ago Jul 18, 2013
VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
Replicel and Shiseido Complete Collaboration and Technology Transfer Agreement on Technology for Treating Pattern Baldness
12 years ago Jul 10, 2013
VANCOUVER, BC – July 11, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
12 years ago May 28, 2013
Tokyo, Japan and Vancouver, Canada – May 29, 2013 – RepliCel Life Sciences Inc. (the...
Events
Dr. Jerry Shapiro to Present RepliCel Data to European Academy of Dermatology and Venereology in Poland
12 years ago May 22, 2013
VANCOUVER, BC – May 23, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...
Press Release
RepliCel Announces Closing of Private Placement
12 years ago May 20, 2013
VANCOUVER, BC – May 21, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.